Inhibition of human polymorphonuclear cell oxidative burst by 17-β-estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin

American Journal of Reproductive Immunology

Volumn 50, Issue 6, 2003, Pages 463-472

  Abrahams, Vikki M ^a   Collins, Jane E ^a   Wira, Charles R ^a   Fanger, Michael W ^a   Yeaman, Grant R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Aryl hydrocarbon receptor; Estrogen receptor; Neutrophil; Superoxide; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; LUCIGENIN; PHORBOL 13 ACETATE 12 MYRISTATE; RESVERATROL; SUPEROXIDE; TAMOXIFEN;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST;

CELL LINE, TUMOR; ESTRADIOL; FEMALE; HUMANS; MALE; NEUTROPHILS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RESPIRATORY BURST; SUPEROXIDES; TETRACHLORODIBENZODIOXIN;

EID: 0344961173     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.8755-8920.2003.00111.x     Document Type: Article

References (61)

1. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest 2000; 80:617-653.
2. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, Wira CR: Flow cytometric analysis of leukocytes in the human female reproductive tract: Comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997; 38:350-359.
3. King A, Loke YW: Uterine large granular lymphocytes: A possible role in embryonic implantation. Am J Obstet Gynecol 1990; 162:308-310.
4. Mueller MD, Lebovic DI, Garrett E, Taylor RN: Neutrophils infiltrating the endometrium express vascular endothelial growth factor: Potential role in endometrial angiogenesis. Fert Steril 2000; 74:107-112.
5. Milne SA, Critchley HOD, Drudy TA, Kelly RW, Baird DT: Perivascular interleukin-8 messenger ribonucleic acid expression in human endometrium varies across the menstrual cycle and in early pregnancy decidua. J Clin Endocrinol Metab 1999; 84:2563-2567.
6. Arici A, Seli E, Senturk LM, Gutierrez LS, Oral E, Taylor HS: Interleukin-8 in the human endometrium. J Clin Endocrinol Metab 1998; 83:1783-1787.
7. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL: Interleukin-8 induces proliferation of endometrial stromal cells: A potential autocrine growth factor. J Clin Endocrinol Metab 1998; 83:1201-1205
8. Prabhala RH, Wira CR: Influence of estrous cycle and estradiol on mitogenic responses of splenic T- and B-lymphocytes. Adv Exp Med Biol 1995; 371A: 379-381.
9. Wira CR, Rossoll RM, Kaushic C: Antigen-presenting cells in the female reproductive tract: Influence of estradiol on antigen presentation by vaginal cells. Endocrinology 2000; 141:2877-2885.
10. Ahmed SA: The immune system as a potential target for environmental estrogens (endocrine disrupters): A new emerging field. Toxicology 2000; 150:191-206.
11. Buyon JP, Korchak HM, Rutherford LE, Ganguly M, Weissmann G: Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum 1984; 27: 623-630.
12. Miyagi M, Aoyama H, Morishita M, Iwamoto Y: Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. J Peridontol 1992; 63:28-32.
13. Ito I, Hayashi T, Yamada K, Kuzuya M, Naito M, Iguchi A: Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system. Life Sci 1995; 56:2247-2253.
14. Békési G, Kakucs R, Várbíró S, Rácz K, Sprintz D, Fehér J, Székács: In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 2000; 65:889-894.
15. Polan ML, Loukides J, Nelson P, Carding S, Diamond M, Walsh A, Bottomly K: Progesterone and estradiol modulate interleukin-1b messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 1989; 69:1200-1206.
16. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS: Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 1994; 93:17-25.
17. Stefano GB, Cadet P, Breton C, Goumon Y, Prevot V, Dessaint JP, Beauvillain JC, Roumier AS, Welters I, Salzet M: Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: Evidence of a cell surface estrogen receptor. Blood 2000; 95:3951-3958.
18. Molero L, Garcia-Duran M, Diaz-Recasens J, Rico L, Casado S, Lopez-Farre A: Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: Regulation by estrogen. Cardio Res 2002; 56:43-51.
19. Whitlock JP Jr.: The aromatic hydrocarbon receptor, TCDD action and endocrine homeostasis. TEM 1994; 5:183-188.
20. Safe SH: Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-TCDD and related compounds. Pharmacol Ther 1995; 67:247-281.
21. Kerkvliet NI: Immunological effects of chlorinated dibenzo-p-TCDDs. Environ Health Perspect 1995; 103:47-53.
22. Hahn ME: The aryl hydrocarbon receptor: A comparative perspective. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 121:23-53.
23. Carevic M, Carevic O: The effects of 2,3,7,8-tetrachlorodibenzo-p-TCDD on human polymorphonuclear leucocytes. Arh Hig Rada Toksikol 1994; 45:161-166.
24. Spink DC, Eugster HP, Lincoln DI, Schuetz JD, Schuetz EG, Johnston JA, Kaminsky LS, Gierthy JF: 17 betastradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-TCDD in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 1992; 293:342-348.
25. Tian Y, Ke S, Thomas T, Meeker RJ, Gallo MA: Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-TCDD (TCDD). J Steroid Biochem Mol Biol 1998; 67:17-24.
26. Klinge CM, Kaur K, Swanson HI: The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRα1. Arch Biochem Biophys 2000; 373:163-174.
27. Nguyen TA, Hoivik D, Lee JE, Safe S: Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biocem Biophys 1999; 367:250-257.
28. Wormke M, Castro-Rivera E, Chen I., Safe S: Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikaya endometrial cancer cells. J Steroid Biochem Mol Biol 2000; 72:197-207.
29. Krishnan V, Porter, W, Santostefano M, Wang X, Safe S: Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol Cell Biol 1995; 15:6710-6719.
30. Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M, Safe S: Transcriptional activation of c-fos protooncogene by 17-β-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Endocrinol 1999; 13:1511-1521.
31. Angel KL, Schumacher J, Wolfe DF, Klesius PH, Tyler JW, Carson RL: Effects of estradiol 17 beta implants on hematologic values and the chemiluminescence response of neutrophils of steers. Am J Vet Res 1992; 53:78-82.
32. Ackermann MF, Gasiewicz TA, Lamm KR, Germolec DR, Luster MI: Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetracholordibenzo-p-TCDD. Toxicol Appl Pharmacol 1989; 101:470-480.
33. Parahala RH, Wira CR: Cytokine regulation of the mucosal immune system: In vivo stimulation by interferon-γ of secretory component and immunoglobulin A in uterine secretions and proliferation of lymphocytes from spleen. Endocrinology 1991; 129:2915-2923.
34. Steenland K, Deddens J, Piacitelli L: Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study. Am J Epidemiol 2001; 154: 451-458.
35. Kerr MA, Falconer JS, Bashey A, Swanson Beck J: The effect of C3 levels on yeast opsonisation by normal and pathological sera: Identification of a complement independent opsonin. Clin Exp Immunol 1983; 54:793-800.
36. Yeaman GR, Froebel K, Galea G, Ormerod A, Urbaniak SJ: Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease. Br J Dermatol 1992; 126:60-65.
37. Lang GA, Yeaman GR: Autoantibodies in emdometriosis sera recognize a thomsen-friedenreich-like carbohydrate antigen. J Autoimmun 2001; 16:151-161.
38. Poland A, Glover E, Bradfield CA: Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten. Mol Pharmacol 1991; 39:20-26.
39. Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist of the mixed antiestrogen 4-hydroxytamoxifen. Mol Endocrinol 1997; 11:657-666.
40. Howell A, Osborne CK, Morris C, Wakeling AE: ICI 182, 780 (Faslodex™). Development of a novel, pure antiestrogen. Cancer 2000; 89:817-825.
41. Wang X, Thomsen JS, Santostefano M, Rosengren R, Safe S, Perdew GH: Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. Eur J Pharm 1995; 293:191-205.
42. Ciolino HP, Yeh GC: Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CpYP1A1 expression by resveratrol. Mol Pharm 1999; 56:760-767.
43. Holsapple MP, Snyder NK, Wood SC, Morris DL: A review of 2,3,7,8-tetrachlorodibenzo-p-TCDD-induced changes in immunocompetence: 1991 update. Toxicology 1991; 69:219-255.
44. Perdew GH, Hollenback CE: Evidence for two functionally distinct forms of the human Ah receptor. J Biochem Toxicol 1995; 10:95-102.
45. Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA: Cloning and expression of human Ah receptor cDNA. Mol Pharmacol 1993; 44:911-917.
46. Nawaz Z, Lonard DM, Dennis AP, Smoth CL, O'Malley BW: Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 1999; 96:1858-1862.
47. Saceda M, Lindsey RK, Solomon H, Angeloni SV, Martin, MB: Estradiol regulates estrogen receptor mRNA stability. J Steroid Biochem Mol Biol 1998; 66:113-120.
48. Ma Q, Baldwin KT: 2,3,7,8-tetrachlorodibenzo-p-TCDD-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR. J Bio Chem 2000; 275:8432-8438.
49. Muramatsu M, Inoue S: Estrogen receptors: How do they control reproductive and nonreproductive functions? Biochem Biophys Res Comm 2000; 270:1-10.
50. Nauseef WM: The NADPH-dependent oxidase of phagocytes. Proc Assoc Am Physicians 1999; 111: 373-382.
51. Pongracz J, Lord JM: Superoxide production in human neutrophils: Evidence for signal redundancy and the involvement of more than one PKC isoenzyme class. Biochem Biophys Res Comm 1998; 247:624-629.
52. Nixon JB, McPhail LC: Protein kinase C (PKC) isoforms translocate to triton-insoluble fractions in stimulated human neutrophils: Correlation of conventional PKC with activation of NADPH oxidase. J Immunol 1999; 163:4574-4582.
53. Long WP, Proy-Grant M, Tsai JC, Perdew GH: Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 1998; 53:691-700.
54. Rebecchi IM, Ferreira Nova N, Julian Y, Campa A: Oxidative metabolism and release of myeloperoxidase from polymorphonuclear leukocytes obtained from blood sedimentation in a Ficoll-Hypaque gradient. Cell Biochem Funct 2000; 18:127-132.
55. Kharat I, Saatcioglu F: Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. J Biol Chem 1996; 271:10533-10537.
56. Hoivik D, Willett K, Wilson C, Safe S: Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J Biol Chem 1997; 272:30270-30274.
57. Poiger H, Schlatter C: Influence of solvents and adsorbents on dermal and intestinal absorption of TCDD. Food Cosmet Toxicol 1980; 18:477-481.
58. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL: Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetracholorodibenzo-p-TCDD. Fundam Appl Toxicol 1993; 21:433-434.
59. Rier SE, Martin DC, Bowman RE, Becker JL: Immunoresponsiveness in endometriosis: Implications of estrogenic toxicants. Environ Health Perspect 1995; 103(Suppl. 7):151-156.
60. Lathbury LJ, Salamonsen LA: In-vitro studies of the potential role of neutrophils in the process of menstruation. Mol Hum Reprod 2000; 6:899-906.
61. Plante M, De Lamirande E, Gagnon C: Reactive oxygen species released by activated neutrophils, but not by deficient spermatozoa, are sufficient to affect normal sperm motility. Fert Steril 1994; 62:387-393.